Cynthia Matossian discusses intense pulsed light (IPL), a new treatment for meibomian gland dysfunction, which is one of the causes of dry eye disease.
Share this Video
Related Videos In Ocular Surface Disease
Chhavi Saini, ASCRS 2022: Clinical outcomes of Boston keratoprosthesis type 2
The Boston Keratoprosthesis type II (BK2) device may be the only viable option to salvage vision in patients with severe cicatrizing ocular surface disease. The prior BK2 model was modified to the present day (click-on) model in 2009. The clinical outcomes of the current click-on BK2 model is discussed in this touchOPHTHALMOLOGY interview with Dr […]
Marie Bannier-Hélaouët, ESCRS 2021: Lacrimal Gland Organoids
It was a pleasure to interview Marie Bannier-Hélaouët (Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences, Utrecht, Netherlands) about her fascinating research into lachrymal gland organoids, which have great potential for the future treatment of lachrymal gland dysfunction. Questions What are the consequences of lachrymal gland dysfunction, and what have been the limitations in […]
Jennifer Loh: ASCRS 2020 – A Novel, Targeted, Open Eye, Thermal Therapy for Treatment of Dry Eye
Jennifer Loh (South Florida Vision Associates, Fort Lauderdale, Florida, USA) discusses unmet needs in the treatment of dry eye, and gives an overview of the TearCare system and the efficacy and safety findings of the OLYMPIA clinical trial. Questions: 1. What are the major unmet needs in the treatment of dry eye? (0:12) 2. Could […]
Journal articles and more to your inbox
Get the latest clinical insights from touchOPHTHALMOLOGYSign me up!